Literature DB >> 19016723

The prognostic significance of 8p21 deletion in multiple myeloma.

T Sutlu, E Alici, M Jansson, A Wallblom, M S Dilber, G Gahrton, H Nahi.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19016723     DOI： 10.1111/j.1365-2141.2008.07454.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Racial disparities, cancer and response to oxidative stress.

Authors:  Jie Zhang; Zhi-Wei Ye; Danyelle M Townsend; Chanita Hughes-Halbert; Kenneth D Tew
Journal:  Adv Cancer Res       Date:  2019-04-23       Impact factor: 6.242

2.  In search of the molecular consequences of 8p21 deletion in multiple myeloma: commentary on Gmidéne et al.

Authors:  Tolga Sutlu; Evren Alici; Gösta Gahrton; Hareth Nahi
Journal:  Med Oncol       Date:  2013-04-09       Impact factor: 3.064

3.  American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Authors:  Sergio Giralt; Laurent Garderet; Brian Durie; Gordon Cook; Gosta Gahrton; Benedetto Bruno; Paremesweran Hari; Henk Lokhorst; Phillip McCarthy; Amrita Krishnan; Pieter Sonneveld; Harmut Goldschmidt; Sundar Jagannath; Bart Barlogie; Maria Mateos; Peter Gimsing; Orhan Sezer; Joseph Mikhael; Jin Lu; Meletios Dimopoulos; Amitabha Mazumder; Antonio Palumbo; Rafat Abonour; Kenneth Anderson; Michel Attal; Joan Blade; Jenny Bird; Michele Cavo; Raymond Comenzo; Javier de la Rubia; Hermann Einsele; Ramon Garcia-Sanz; Jens Hillengass; Sarah Holstein; Hans Erik Johnsen; Douglas Joshua; Guenther Koehne; Shaji Kumar; Robert Kyle; Xavier Leleu; Sagar Lonial; Heinz Ludwig; Hareth Nahi; Anil Nooka; Robert Orlowski; Vincent Rajkumar; Anthony Reiman; Paul Richardson; Eloisa Riva; Jesus San Miguel; Ingemar Turreson; Saad Usmani; David Vesole; William Bensinger; Muzaffer Qazilbash; Yvonne Efebera; Mohamed Mohty; Christina Gasparreto; James Gajewski; Charles F LeMaistre; Chris Bredeson; Phillipe Moreau; Marcelo Pasquini; Nicolaus Kroeger; Edward Stadtmauer
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-30       Impact factor: 5.742

4.  Pyk2 promotes tumor progression in multiple myeloma.

Authors:  Yu Zhang; Michele Moschetta; Daisy Huynh; Yu-Tzu Tai; Yong Zhang; Wenjing Zhang; Yuji Mishima; Jennifer E Ring; Winnie F Tam; Qunli Xu; Patricia Maiso; Michaela Reagan; Ilyas Sahin; Antonio Sacco; Salomon Manier; Yosra Aljawai; Siobhan Glavey; Nikhil C Munshi; Kenneth C Anderson; Jonathan Pachter; Aldo M Roccaro; Irene M Ghobrial
Journal:  Blood       Date:  2014-09-12       Impact factor: 22.113

5.  Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.

Authors:  Benoit Hedan; Rachael Thomas; Alison Motsinger-Reif; Jerome Abadie; Catherine Andre; John Cullen; Matthew Breen
Journal:  BMC Cancer       Date:  2011-05-26       Impact factor: 4.430

6.  Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.

Authors:  Adil Doganay Duru; Tolga Sutlu; Ann Wallblom; Katarina Uttervall; Johan Lund; Birgitta Stellan; Gösta Gahrton; Hareth Nahi; Evren Alici
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

Review 7.  The genetic architecture of multiple myeloma.

Authors:  Steven M Prideaux; Emma Conway O'Brien; Timothy J Chevassut
Journal:  Adv Hematol       Date:  2014-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.